Following reports indicating a close association between the presence of a long Y chromosome in males and the risk of spontaneous abortion in their female partners, the incidence of spontaneous fetal loss was investigated in four family lines whose patrilineary ancestors emigrated from France to Canada during the second half of the seventeenth century. In two of the lines the males were carriers of a Yq+, in the other two the males had a Yq- or a normal Y chromosome. Results showed that in one of family lines with a Yq+, 17/26 (65.4%) wives had 33 (2.8%) spontaneous abortions in 151 pregnancies, whereas in each of the three other family lines 7/30 (23.3%) wives aborted 8 (4.9%), 15 (7.5%) and 10 (5.7%) times in 165, 200 and 175 pregnancies respectively. The high incidence of fetal loss found in one of the family lines whose males have a long Y chromosome correlates with previous observations on the influence of Yq+ on spontaneous abortions, and draws attention to the inheritable nature of this peculiarity. However, the low incidence of miscarriages observed in the other family line carrying a Yq+ seems to indicate that long Y chromosomes are of various types and could be produced by several mechanisms. Yq- does not seem to represent an increased risk of pregnancy loss. Results also demonstrated that while a long Y chromosome may affect the viability of the zygote, it does not affect the fertility of its carrier.

Download full-text PDF

Source

Publication Analysis

Top Keywords

family lines
20
spontaneous abortions
12
long chromosome
12
fetal loss
8
lines males
8
family
6
lines
6
chromosome
5
spontaneous
5
influence length
4

Similar Publications

Dysregulation of choline phospholipid metabolism and overexpression of phosphatidylcholine-specific phospholipase C (PC-PLC) is implicated in various cancers. Current known enzyme inhibitors include compounds based on a 2-morpholino-5--benzylamino benzoic acid, or hydroxamic acid, scaffold. In this work, 81 compounds were made by modifying this core structure to explore the pharmacophore.

View Article and Find Full Text PDF

DNA damage response mutations enhance the antitumor efficacy of ATR and PARP inhibitors in cholangiocarcinoma cell lines.

Oncol Lett

March 2025

Program in Translational Medicine, Chakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Samutprakarn 10540, Thailand.

Cholangiocarcinoma (CCA) is a biliary tract carcinoma that is challenging to treat due to its heterogeneity and limited treatment options. Genetic alterations in DNA damage response (DDR) pathways and homologous recombination (HR) defects are common in CCA. This has prompted interest in the use of ataxia telangiectasia and Rad3-related protein (ATR) and poly(ADP-ribose) polymerase (PARP) inhibitors to treat CCA.

View Article and Find Full Text PDF

Solute carrier family 25 member 1 (SLC25A1) affects lipid metabolism and energy regulation in multiple types of tumor cell, affecting their proliferation and survival. To the best of our knowledge, however, the impact of SLC25A1 on the proliferation and survival of esophageal squamous cell carcinoma (ESCC) cells has yet to be explored. Here, SLC25A1 expression was detected in ESCC tissues and cell lines.

View Article and Find Full Text PDF

Purpose: Colorectal cancer (CRC) is a leading cause of cancer-related mortality worldwide. The Fat mass and obesity-associated protein (FTO), a genetic variant associated with obesity, significantly impact the energetic metabolism of mechanical tumors. However, research on the function of FTO in CRC is scarce.

View Article and Find Full Text PDF

Background: Poly (ADP-Ribose) polymerase inhibitors are approved for treatment of tumors with BRCA1/2 and other homologous recombination repair (HRR) mutations. However, clinical responses are often not durable and treatment may be detrimental in advanced cancer due to excessive toxicities. Thus we are seeking alternative therapeutics to enhance PARP-directed outcomes.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!